-
Viper LT PCR Accessory Kit
SKU/REF 442967
-
BD Viper™ Neutralization Pouch
SKU/REF 441354
FDA approved for all three screening paradigms:
In the post-vaccination era the prevalence of high-risk genotypes may change making it crucial to identify high-risk genotypes individually.
Extended genotyping supports risk stratification and persistence monitoring to guide patient management1-5
Make more informed decisions with the extended genotyping information you need to assess each patient’s risk for confident follow-up decisions1-5
The BD Onclarity™ HPV assay reports individual results for 6 of the 14 high-risk genotypes and grouped results for the remaining 8 high-risk genotypes.12